Skip to main content
OpenTrials
Completed

NCT Number: NCT03461029

Bispectral Index Monitoring During Anesthesiologist - Directed Sedation in Scheduled Colonoscopies

The aim of the study is to establish and identify the level of sedation that is performed in the endoscopy rooms of Galdakao Hospital. To do this, the investigators used the BIS monitoring system, which obtains objective values in real time from the anesthesia performed. The monitoring is completed with basic parameters validated by European guidelines (heart rate, blood pressure, oxygen saturation and respiratory rate), capnography and Ramsay sedation scale, widely validated for use outside the operating room. The main work hypothesis was that in at least 10% of the patients BIS values compatible with moderate or deep sedation would be obtained (BIS <65).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Galdakao-Usansolo

Galdakao, Vizcaya, 48960, Spain

About this study

Observational study in patients undergoing scheduled colonoscopy in endoscopy rooms of the Galdakao-Usansolo Hospital. The investigators objectified the level of sedation that was performed in these procedures using Bispectral Index Monitoring, as well as the total dose of medication required and the level of satisfaction obtained after completing the sedation. The incidence of hemodynamic and respiratory complications observed was included, as well as the treatment needed to solve them.

A total of 196 patients were needed to obtain statistically significant results. Qualitative variables are expressed in the form of freguencies and percentages and continuous variables in the form of means and stnadard deviations. Comparisions of percentages were made by the Chi square test and the difference of means in the continuous variables by the t test.Stadistical significance will be assumed when p<0.05. All estadistical analyzes were carried out using SAS V9.4 (SAS Institute, Inc., Carey, NC).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Indication of scheduled colonoscopy.
  • Classification of physical status ASA I, II and III.
  • Intermitent or persistent mild asthma.
  • Body Mass Index (BMI) < 35 kg/m2.
  • Intact neurological capacity.
  • Acceptance to participate in the study after signing written informed consent.

Exclusion criteria

  • ASA IV.
  • BMI > 35 kg/m2.
  • Allergy to any of the medications using in sedation, or its components.
  • Known mental or neurological disease.
  • Chronic Obstructive Pulmonary Disease (COPD) or Obstructive Sleep Apnea.
  • Chronic opiate users.
  • Refusal to participate in the study.

Treatment and study plan

BIS monitor

Device

The investigators placed on the forehead of all patients the sensor BIS quatroTM, that connects with the monitor, and they registered sedation and recorded the values obtained.

Primary outcomes

  1. Level of sedation

    Time frame: 1 year.

    Sedation measured by Bispectral Index Monitoring.

Secondary outcomes

  1. Complications related to sedation.

    Time frame: 1 year.

    Complications were measured: hypotension, bradicardia, apnea and low oxygen saturation. The medications or maneuvers that were necessary to correct these complications were also evaluated.

  2. Level of satisfaction with the sedation.

    Time frame: 1 year.

    The investigators distributed a satisfaction questionnaire to all patients after colonoscopy to find their opinion about the quality of sedation.

Sponsors and collaborators

Lead sponsor

Hospital Galdakao-Usansolo

Other Gov

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Mar 9, 2018
Registry last updated
Mar 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.